Russia began to export drug for the treatment of coronavirus infection “Aviewer” in the Republic of Belarus in the near future the drug will be delivered to Kazakhstan. On the production and supply told the Russian direct investment Fund (RDIF) and a group of companies “Chemrar”.
“The supply in June was implemented in 35 regions across Russia and in the Republic of Belarus. Soon the supply of “Avifauna” will also be implemented in the Republic of Kazakhstan, which has already been agreed. Within one month will be produced over 100 thousand courses”, – stated in the message of the parties.
In June produced the first 100 thousand “of Avifauna”, exceeding the original production plan at the level of 60 thousand courses. Joint venture, FUND and Ledger Chemrar provided an additional opportunity to increase production capacity three times, up to 300 thousand courses per month that will satisfy the domestic demand for the drug and the start of delivery of the drug to the international market.
“Aviewer” may 29, received a registration certificate from the Ministry of health of the Russian Federation and became the world’s first drug against the coronavirus that contains active substance favipiravir.